Joe Fiandra Access to Home Infusion Act of 2025

Hozzl · 2025-12-12T09:07:46Z

Explore the details of House Bill 4993 Joe Fiandra Access to Home Infusion Act of 2025 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/12/2025, 9:07 AM

Summary of Bill HR 4993

The Joe Fiandra Access to Home Infusion Act of 2025, designated as H.R. 4993 in the 119th Congress, was introduced on August 19, 2025. The bill aims to improve access to home infusion services for patients by potentially outlining provisions related to coverage, reimbursement, or standards for home infusion therapy. Further specifics of the bill's directives or actions proposed can be accessed through the provided link to the official PDF version of the bill.

Read the Full Bill

Formatted XML

Current Status of Bill HR 4993

Bill HR 4993 is currently in the status of Bill Introduced since August 19, 2025. Bill HR 4993 was introduced during Congress 119 and was introduced to the House on August 19, 2025. Bill HR 4993's most recent activity was Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0. as of December 10, 2025

Bipartisan Support of Bill HR 4993

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 4993

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 4993

Joe Fiandra Access to Home Infusion Act of 2025

To amend title XVIII of the Social Security Act to provide coverage of external infusion pumps and non-self-administrable home infusion drugs under the Medicare program.

Comments

Camilo Greenberg

547

5 months ago

I don't like this bill. How will it affect me in the long run?

Scarlett Montgomery

548

4 months ago

I'm not really sure what this bill is all about, but it seems like it could have some impact on me. I'm not too thrilled about it, but I guess we'll have to wait and see what happens.